Page last updated: 2024-11-02

oxybutynin and Hemorrhagic Disease of Newborn

oxybutynin has been researched along with Hemorrhagic Disease of Newborn in 1 studies

oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.

Hemorrhagic Disease of Newborn: Neonatal nasogastric or intracranial hemorrhage caused by vitamin K deficiency.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hutton, ARJ1
Quinn, HL1
McCague, PJ1
Jarrahian, C1
Rein-Weston, A1
Coffey, PS1
Gerth-Guyette, E1
Zehrung, D1
LarraƱeta, E1
Donnelly, RF1

Other Studies

1 other study available for oxybutynin and Hemorrhagic Disease of Newborn

ArticleYear
Transdermal delivery of vitamin K using dissolving microneedles for the prevention of vitamin K deficiency bleeding.
    International journal of pharmaceutics, 2018, Apr-25, Volume: 541, Issue:1-2

    Topics: Administration, Cutaneous; Animals; Drug Liberation; Humans; Infant, Newborn; Injections, Intramuscu

2018